JMI Syringes & Medical Devices Ltd.
DDSE:JMISMDL121.80
BDT
-0.60
(-0.49%)
JMI Syringes & Medical Devices Ltd.
DSE:JMISMDL
(Dhaka Stock Exchange)
Recent
price
121.80
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- JMI Syringes & Medical Devices Ltd. is a Bangladesh-based medical technology company engaged in the manufacturing, marketing, and distribution of precision safety syringes, infusion equipment, and disposable diagnostic and surgical medical devices. Founded in 1999 as JMI-Bangla Co. Ltd., converted into a public limited company in 2002, and renamed in 2010, the company is headquartered in Dhaka, Bangladesh, operates manufacturing facilities in Chauddagram, Cumilla, and functions as a flagship publicly traded entity of the JMI Group (Ticker: DSE:JMISMDL). The company operates across primary healthcare and specialized clinical segments, serving government health directorates, non-governmental organizations, private hospital networks, and retail pharmaceutical channels. Its core product portfolio encompasses safety injection systems, including World Health Organization (WHO) prequalified K1 auto-disable (AD) immunization syringes, standard disposable hypodermic syringes, and insulin syringes; infusion and fluid management systems, such as intravenous (IV) infusion sets, blood transfusion sets, scalp vein sets, and three-way stopcocks; vascular access and drainage devices, including IV cannulas, Nelaton catheters, suction catheters, Ryle's tubes, infant feeding tubes, and wound drain systems; and specialized clinical disposables and diagnostics, including Copper-T intrauterine contraceptive devices (IUCD), umbilical cord clamps, blood lancets, spinal needles, alcohol prep pads, first aid bandages, and biohazard sharps safety boxes. In recent developments, JMI Syringes & Medical Devices Ltd. has expanded its manufacturing capacity and modernized its automated production lines to satisfy surging demand for WHO-prequalified auto-disable syringes across global immunization initiatives and national health programs. The company continues to leverage technical collaboration and strategic synergy within the broader JMI Group alliance with Japan-based Nipro Corporation, supporting ongoing quality enhancement, product innovation, and compliance with international regulatory frameworks including ISO 13485 and CE standards. In addition, the company has broadened its international commercial footprint, exporting medical disposables to nearly 40 countries across Asia, Europe, North America, and the Middle East, while executing domestic pricing realignments and operational cost-efficiency measures to sustain double-digit earnings growth and strengthen supply-chain resilience.